The price of Femring 0.05 mg (estradiol vaginal ring) can vary depending on the pharmacy and insurance coverage. On GoodRx, the cash price for a 30-day supply of Femring 0.05 mg is approximately $155, although discounts are often available [1].
How can I find the cheapest price for Femring?
To find the most affordable option for Femring, it is recommended to compare prices across different pharmacies. GoodRx provides a platform to check current prices and available coupons at local pharmacies [1]. Your insurance plan may also offer a lower copay for the medication.
What is Femring used for?
Femring is a type of hormone therapy used to treat moderate to severe symptoms of vulvar and vaginal atrophy (VVA) due to menopause. It delivers estradiol, a form of estrogen, directly into the vaginal tissues [2].
How does Femring work?
Femring is a vaginal ring that is inserted into the vagina. It slowly releases a low dose of estradiol over a 90-day period. The estrogen absorbed from the ring helps to alleviate symptoms like vaginal dryness, burning, and itching associated with menopause [2].
When does Femring's patent expire?
Information regarding the specific patent expiry date for Femring is not readily available through general public sources. DrugPatentWatch.com is a resource that tracks pharmaceutical patents and exclusivity periods, which could provide more detailed information for those with a specific interest in patent timelines [3].
Are there alternatives to Femring?
Yes, there are several alternative treatments for vaginal dryness and other menopausal symptoms. These include other vaginal estrogen products, such as creams, tablets, and different types of rings, as well as non-estrogen therapies and lifestyle adjustments [4].
What are the side effects of Femring?
Common side effects of Femring can include headache, breast pain or tenderness, abdominal pain, vaginal bleeding or spotting, and an increased risk of vaginal yeast infections [2]. Serious side effects, though rare, can occur with estrogen therapy, and it is important to discuss these risks with a healthcare provider [2, 5].
Who manufactures Femring?
Femring is manufactured by Cadence Pharmaceuticals [6].
What clinical data supports Femring's use?
Clinical studies have demonstrated the efficacy of Femring in reducing the symptoms of VVA. These studies typically assess improvements in vaginal pH, maturation index, and patient-reported symptoms [2].
What are the risks associated with vaginal estrogen therapy like Femring?
While vaginal estrogen therapy is generally considered safe for treating VVA, there are potential risks, particularly for individuals with a history of certain conditions. These risks can include an increased chance of blood clots, stroke, heart attack, and certain types of cancer, especially with systemic absorption of estrogen. A thorough discussion with a healthcare provider is crucial to weigh the benefits against the risks [2, 5].
Can I use Femring if I have certain medical conditions?
Femring should not be used by individuals who have unexplained vaginal bleeding, have or have had breast cancer or other estrogen-dependent cancer, or have a history of blood clots or stroke. It is essential to consult with a healthcare provider about your complete medical history before starting Femring [2].
How is Femring different from other vaginal estrogen products?
Femring is a sustained-release vaginal ring designed to be worn for 90 days, providing continuous estrogen delivery. Other vaginal estrogen products, such as creams and tablets, are typically used daily or a few times a week and may have different dosing schedules and absorption rates [2, 4].
---
Sources:
1. GoodRx. "Femring Prices, Coupons, and Patient Assistance Programs." Accessed October 26, 2023. https://www.goodrx.com/femring
2. National Institutes of Health. "Estrogen Vaginal Products." MedlinePlus. Accessed October 26, 2023. https://medlineplus.gov/druginfo/meds/a614029.html
3. DrugPatentWatch.com. Accessed October 26, 2023. https://drugpatentwatch.com/
4. Mayo Clinic. "Vaginal estrogen for menopause." Accessed October 26, 2023. https://www.mayoclinic.org/diseases-conditions/menopause/in-depth/vaginal-estrogen/art-20047502
5. U.S. Food & Drug Administration. "FDA Orders Warning Label Changes for Vaginal Estrogen Products." Accessed October 26, 2023. https://www.fda.gov/drugs/drug-safety-and-availability/fda-orders-warning-label-changes-vaginal-estrogen-products
6. DailyMed. "Femring." National Library of Medicine. Accessed October 26, 2023. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b9710287-f4c9-455b-857a-c679e673c50b